This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
| Yesterday’s UK 100 Leaders | Price (p) | % Chg |
| Admiral Group | 1,986.5 | 5.0% |
| Next | 5,420.0 | 4.8% |
| RS Group | 906.0 | 4.4% |
| Prudential | 902.4 | 3.0% |
| Smith & Nephew | 1,030.0 | 2.6% |
| Yesterday’s UK 100 Laggards | Price (p) | % Chg |
| Ocado Group | 668.4 | -5.0% |
| Informa | 550.6 | -3.7% |
| Harbour Energy | 376.1 | -3.3% |
| Glencore | 510.4 | -2.7% |
| Flutter Entertainment | 11465.0 | -2.7% |
| Major World Indices | Price | % Chg | 1 YEAR |
| UK 100 INDEX | 7,375 | 1.1% | -0.1% |
| DOW JONES INDUS. AVG | 33,715 | 3.7% | -6.1% |
| DAX INDEX | 14,146 | 3.5% | -12.0% |
| NIKKEI 225 | 28,264 | 3.0% | -3.5% |
| S&P/ASX 200 INDEX | 7,158 | 2.8% | -3.0% |
| Commodities | Units | Price | % Chg |
| WTI Crude Oil (Nymex) | USD/bbl. | 88.60 | 2.46% |
| Brent Crude (ICE) | USD/bbl. | 95.88 | 2.36% |
| Gold Spot | USD/t oz. | 1,761 | 0.3% |
| Copper (Comex) | USd/lb. | 386 | 2.6% |
Click graph to enlarge
The UK 100 is called to open +45 points this morning at 7420. The UK 100 is expected to open higher on Friday, extending Thursday's rally after a US inflation reading undershot market expectations sending US markets sharply higher. Asian markets also made strong gains. This morning, UK GDP fell 0.2% between July and September according to the first quarterly estimate from the Office for National Statistics (ONS), better than City forecasts for a decline of 0.5%. At the close on Wall Street, the Dow Jones was up 1,198 points, or 3.69%, to 33,712.21, the S&P surged 207.38 points, or 5.53%, to 3,955.95 and the Nasdaq roared 761 points higher, or 7.35%, to 11,114.15.
AstraZeneca says Imfinzi and Imjudo have been approved in the US with chemo for non-small lung cancer.
Beazley state their gross premiums written at Sept 30th were $3.98bn (2021: $3.27bn) as they record a loss of $120m net of reinsurance for Hurricane Ian.
GlaxoSmithKline are to restrict second-line maintenance indication for Zejula at the request of the FDA.
Halma appoints Steve Gunning as their new CFO, effective from Jan 16th 2023.
Redrow says their net private reservations in the first 18 weeks of FY23 came in at £515m (2021: £639m) as they expect average outlets for FY23 to be 120, in line with guidance from September. They reiterate overall build cost inflation estimate of 7% for FY23. They expect a FY23 operating margin of around 18% vs 19% in FY22.
No new broker comments
3i Group
Assura
B&M European Value Retail
Beazley
Endeavour Mining
Softcat
WH Smith
S4 Capital
UK Gross Domestic Product
UK Industrial Production
UK Manufacturing Production
EU EcoFin Meeting
German Harmonized Index of Consumer Prices
UK NIESR GDP Estimate
US Michigan Consumer Sentiment Index
UoM 5-year Consumer Inflation Expectation
UK 100 companies going ex-dividend on 17th November 2022:
Pershing Square Holdings
Bunzl
Unilever
GSK
DCC
AVEVA Group
B&M European Value Retail S.A.
UK 250 companies going ex-dividend on 10th November 2022:
Genus
Fidelity Emerging Markets
ICG Enterprise Trust
Bytes Technology Group
Murray Income Trust
Scottish American Investment Company
UK Commercial Property REIT
Balanced Commercial Property Trust
Firstgroup
NextEnergy Solar Fund
Renewables Infrastructure Group
For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.